Medicine
Hydrochlorothiazide and Triamterene 50 mg/75 mg tablet
Hydrochlorothiazide and Triamterene 50 mg/75 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25ºC (68º to 77ºF) Protect from light.
Key facts
- Active ingredient (INN)
- Hydrochlorothiazide and Triamterene
- Brand
- Sold under the generic name
- Strength
- 50 mg/75 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 56 more
- Manufacturers
- Zydus LifesciencesIndiaBryant Ranch PrepackA-S Medication SolutionsAdvagen PharmaActavis PharmaApotexBluePoint Laboratories13 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25ºC (68º to 77ºF) Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 September 1993
- Identifiers
- RxCUI 310818, 310812DailyMed set ID 27b8f965-d73f-411c-aae6-bcae6e281113, 5ee165a3-39a4-4d12-aff2-a6fb3309ce39, 5ba2c08b-5ce5-4967-bc3b-2c73df9865af +16NDC 50090-6736, 70518-4351, 71335-0326 +16Application ANDA208360, ANDA216211, ANDA071251 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 13 labelers. The register lists 59 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 68382-857-01 | Zydus LifesciencesIndia | 4 September 2018 |
| 500 tablet in 1 bottle | 68382-857-05 | Zydus LifesciencesIndia | 4 September 2018 |
| 1000 tablet in 1 bottle | 68382-857-10 | Zydus LifesciencesIndia | 4 September 2018 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 68382-857-77 | Zydus LifesciencesIndia | 4 September 2018 |
| 1000 tablet in 1 bottle | 70771-1362-0 | Zydus LifesciencesIndia | 4 September 2018 |
| 100 tablet in 1 bottle | 70771-1362-1 | Zydus LifesciencesIndia | 4 September 2018 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 70771-1362-4 | Zydus LifesciencesIndia | 4 September 2018 |
| 500 tablet in 1 bottle | 70771-1362-5 | Zydus LifesciencesIndia | 4 September 2018 |
| 100 tablet in 1 bottle, plastic | 0591-0348-01 | Actavis Pharma | 23 September 1993 |
| 500 tablet in 1 bottle, plastic | 0591-0348-05 | Actavis Pharma | 23 September 1993 |
| 1000 tablet in 1 bottle, plastic | 0591-0348-10 | Actavis Pharma | 23 September 1993 |
| 1000 tablet in 1 bottle | 72888-095-00 | Advagen Pharma | 2 February 2023 |
| 100 tablet in 1 bottle | 72888-095-01 | Advagen Pharma | 2 February 2023 |
| 500 tablet in 1 bottle | 72888-095-05 | Advagen Pharma | 2 February 2023 |
| 30 tablet in 1 bottle | 72888-095-30 | Advagen Pharma | 2 February 2023 |
| 100 tablet in 1 bottle | 60505-2657-1 | Apotex | 21 September 2009 |
| 500 tablet in 1 bottle | 60505-2657-5 | Apotex | 21 September 2009 |
| 7000 tablet in 1 bottle | 60505-2657-7 | Apotex | 21 September 2009 |
| 30 tablet in 1 bottle | 63629-2585-1 | Bryant Ranch Prepack | 7 January 2005 |
| 15 tablet in 1 bottle | 63629-2585-2 | Bryant Ranch Prepack | 23 September 2010 |
| 90 tablet in 1 bottle | 63629-2585-3 | Bryant Ranch Prepack | 31 July 2015 |
| 100 tablet in 1 bottle | 63629-2585-4 | Bryant Ranch Prepack | 22 December 2021 |
| 7 tablet in 1 bottle | 63629-2585-5 | Bryant Ranch Prepack | 25 September 2019 |
| 30 tablet in 1 bottle | 71335-0326-1 | Bryant Ranch Prepack | 30 December 2021 |
| 15 tablet in 1 bottle | 71335-0326-2 | Bryant Ranch Prepack | 30 October 2024 |
| 90 tablet in 1 bottle | 71335-0326-3 | Bryant Ranch Prepack | 30 October 2024 |
| 100 tablet in 1 bottle | 71335-0326-4 | Bryant Ranch Prepack | 19 July 2023 |
| 7 tablet in 1 bottle | 71335-0326-5 | Bryant Ranch Prepack | 30 October 2024 |
| 30 tablet in 1 bottle | 71335-2338-1 | Bryant Ranch Prepack | 30 January 2024 |
| 15 tablet in 1 bottle | 71335-2338-2 | Bryant Ranch Prepack | 30 January 2024 |
| 90 tablet in 1 bottle | 71335-2338-3 | Bryant Ranch Prepack | 30 January 2024 |
| 100 tablet in 1 bottle | 71335-2338-4 | Bryant Ranch Prepack | 30 January 2024 |
| 7 tablet in 1 bottle | 71335-2338-5 | Bryant Ranch Prepack | 30 January 2024 |
| 30 tablet in 1 bottle | 50090-1834-0 | A-S Medication Solutions | 19 May 2015 |
| 100 tablet in 1 bottle | 50090-1834-2 | A-S Medication Solutions | 19 May 2015 |
| 90 tablet in 1 bottle | 50090-1834-5 | A-S Medication Solutions | 29 July 2015 |
| 30 tablet in 1 bottle | 50090-6736-0 | A-S Medication Solutions | 12 October 2023 |
| 100 tablet in 1 bottle | 50090-6736-2 | A-S Medication Solutions | 20 October 2023 |
| 90 tablet in 1 bottle | 50090-6736-5 | A-S Medication Solutions | 20 October 2023 |
| 100 tablet in 1 bottle | 68001-328-00 | BluePoint Laboratories | 30 April 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 2 December 1965 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Hydrochlorothiazide and Triamterene
Clinical summary
Hydrochlorothiazide and Triamterene is a fixed-dose combination of a potassium-sparing diuretic and a thiazide diuretic. It is available as tablets and capsules for oral use. MedsAcross supplies Hydrochlorothiazide and Triamterene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Hydrochlorothiazide and TriamtereneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Triamterene and Hydrochlorothiazide prescribing information (Zydus Lifesciences) · U.S. National Library of Medicine, DailyMed
Need Hydrochlorothiazide and Triamterene 50 mg/75 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.